Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population

Journal of Endovascular Therapy

Volumn 19, Issue 3, 2012, Pages 316-324

  Tekieli, Lukasz ^a,b   Pieniazek, Piotr ^a,b   Musialek, Piotr ^a,b   Kablak Ziembicka, Anna ^a,b   Przewlocki, Tadeusz ^a,b   Trystula, Mariusz ^a,b   Moczulski, Zbigniew ^b   Dzierwa, Karolina ^a,b   Paluszek, Piotr ^b   Podolec, Piotr ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Balloon expandable stent; Carotid artery; Carotid stent; Coronary stent; Drug eluting stent; In stent stenosis; Restenosis; Self expanding stent; Stenosis; Zotarolimus eluting stent

Indexed keywords

ENDEAVOR; RESOLUTE; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CLINICAL ARTICLE; DEVICE SAFETY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE;

AGED; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CAROTID STENOSIS; DRUG-ELUTING STENTS; EMBOLIC PROTECTION DEVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLAND; PROSTHESIS DESIGN; RECURRENCE; SEVERITY OF ILLNESS INDEX; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84864556565     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/11-3805R.1     Document Type: Article

References (29)

1. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke . 2011;42:227-276.
2. Groschel K, Riecker A, Schulz JB, et al. Systematic review of early recurrent stenosis after carotid angioplasty and stenting. Stroke. 2005;36:367-373. (Pubitemid 40170824)
3. Musialek P, Pieniazek P. Restenosis after carotid artery stenting versus endarterectomy: the jury is still out! J Endovasc Ther. 2010;17:271-2.
4. Donas KP, Eisenack M, Torsello G. Balloon angioplasty for in-stent stenosis after carotid artery stenting is associated with an increase in repeat interventions. J Endovasc Ther. 2011;18:720-725.
5. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010;31:2501-2555.
6. Schwarzmaier-D'Assie A, Nyolczas N, Hemetsberger R, et al. Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery. J Endovasc Ther. 2011;18:547-558.
7. Wholey MH, Wholey MH, Bergeron P, et al. Current global status of carotid artery stent placement. Cathet Cardiovasc Diagn. 1998;44:1-6.
8. Wholey MH, Wholey MH, Tan WA, et al. A comparison of balloon-mounted and self-expanding stents in the carotid arteries: immediate and long-term results of more than 500 patients. J Endovasc Ther. 2003;10:171-181. (Pubitemid 36988586)
9. Pieniazek P, Musialek P, Kablak-Ziembicka A, et al. Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS). J Endovasc Ther. 2008;15:249-262. (Pubitemid 351969138)
10. Zhou W, Felkai DD, Evans M, et al. Ultrasound criteria for severe in-stent restenosis following carotid artery stenting. J Vasc Surg. 2008;47:74-80.
11. Nederkoorn PJ, Brown MM. Optimal cut-off criteria for duplex ultrasound for the diagnosis of restenosis in stented carotid arteries: review and protocol for a diagnostic study. BMC Neurol. 2009;9:36.
12. Pieniazek P, Tekieli L, Musialek P, et al. Carotid artery stenting according to 'tailored-CAS' algorithm is associated with a low complication rate in 30-day follow-up. Data analysis from the TARGET-CAS registry. Kardiol Pol. 2012; in press.
13. Musialek P, Pieniazek P, Tracz W, et al. Safety of embolic protection device-assisted and unprotected intravascular ultrasound in evaluating carotid artery atherosclerotic lesions. Med Sci Monit. 2012;18:7-18.
14. Iancu A, Lazar A. Re: "Midterm results of a sirolimus-eluting stent implanted for recurrent carotid in-stent restenosis." [Letter] J Endovasc Ther. 2008;15:706-707.
15. Chen MS, John JM, Chew DP, et al. Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006;151:1260-1264. (Pubitemid 43866610)
16. Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7:893-902.
17. Tepe G, Schmehl J, Claussen CD, et al. Drug coated stents for carotid intervention. J Cardiovasc Surg. 2005;46:249-259. (Pubitemid 43932986)
18. Iancu A, Lazar A. Carotid artery in-stent restenosis in a patient with contralateral total occlusion, resolved with drug-eluting stenting. J Invasive Cardiol. 2007;19:275-279.
19. Leguizamón JH, Azzari F, Schipani G, et al. Midterm results of a sirolimus-eluting stent implanted for recurrent carotid in-stent restenosis temporary cardiac pacing in carotid stenting [Letter]. J Endovasc Ther. 2008;15:379-380.
20. Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006;47:175-181. (Pubitemid 43005183)
21. Leon MB, Nikolsky E, Cutlip DE, et al. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3- year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial. JACC Cardiovasc Interv . 2010;3:1043-1050.
22. Basalus MW, Tandjung K, van Apeldoorn AA, et al. Effect of oversized partial postdilatation on coatings of contemporary durable polymer-based drug-eluting stents: a scanning electron microscopy study. J Interv Cardiol. 2011;24:149-161.
23. Mathur A, Dorros G, Iyer SS, et al. Palmaz stent compression in patients following carotid artery stenting. Cathet Cardiovasc Diagn. 1997;41:137-140. (Pubitemid 27240884)
24. Toma N, Matsushima S, Murao K, et al. Histopathological findings in a human carotid artery after stent implantation. Case report. J Neurosurg. 2003;98:199-204. (Pubitemid 36050469)
25. Gurbel PA, Tantry US. Clopidogrel resistance? Thromb Res. 2007;120:311-321. (Pubitemid 46881255)
26. Chin K. In-stent restenosis: the gold standard has changed. EuroIntervention. 2011;7:Suppl K:K43-K46.
27. Chan YC, Cheng SW. Drug-eluting stents and balloons in peripheral arterial disease: evidence so far. Int J Clin Pract. 2011;6:664-668.
28. Gonzalez A, Drummond M, McCord S, et al. Carotid endarterectomy for treatment of in-stent restenosis. J Vasc Surg. 2011;54:1167-1169.
29. Reichmann BL, van Laanen JH, de Vries JP, et al. Carotid endarterectomy for treatment of in-stent restenosis after carotid angioplasty and stenting. J Vasc Surg. 2011;54:87-92.